Decline in Varicella‐Zoster Virus (VZV)–Specific Cell‐Mediated Immunity with Increasing Age and Boosting with a High‐Dose VZV Vaccine
Myron J. Levin(Unknown), Michael J. Caulfield(United States Military Academy), Paul M. Keller(United States Military Academy), D. Li(United States Military Academy), Ira Chalikonda(United States Military Academy), Jeffrey L. Silber(United States Military Academy), Katia Schlienger(United States Military Academy), Anthony Hayward(Department of Health and Social Care), Robin M. Kaufhold(United States Military Academy), S. J. RUPERT VESSEY(United States Military Academy), William Yang Wang(University of California, Santa Barbara), Christina Y. Chan(United States Military Academy), Ivan S. F. Chan(United States Military Academy), Alan Shaw(Dana-Farber Cancer Institute), Jeffrey G. Smith(United States Military Academy), Debra Barber(Office of Infectious Diseases)
Cited by 320
Related Papers
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
|Nature|2002|1.2k
Recommendations for the Management of Herpes Zoster
|Clinical Infectious Diseases|2006|842